IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caxton Corp

Q2 2021 Holdings

Filed 2021-08-16 | 63 holdings | $16.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Addex Therapeutics LTD(ADXNUSD)SPONSORED ADS00654J107$2.5K265,9400.0%
CTI Biopharma Corp(CTIC1USD)COM12648L601$5.8K2,314,5330.0%
Rezolute Inc(RZLT)COM NEW76200L309$6.1K424,2430.0%
Spdr Gold TR(GLD)GOLD SHS78463V107$6.8K40,8200.0%
Sierra Oncology IncCOM NEW82640U404$8.6K443,9590.1%
Kala Pharmaceuticals IncCOM483119103$9.0K1,704,8490.1%
Savara Inc(SVRA)COM805111101$10.1K5,951,0150.1%
Scynexis Inc(SCYX)COM NEW811292200$11.0K1,488,6230.1%
Molecular Templates IncCOM608550109$16.7K2,137,9910.1%
Strongbridge Biopharma PLCSHS USDG85347105$24.0K8,083,4420.1%
Aldeyra Therapeutics Inc(ALDX)COM01438T106$134.0K11,7840.8%
Charter Communications Inc N(CHTR)CL A16119P108$766.0K1,0624.6%
Cardiff Oncology Inc(CRDF)COM14147L108$15.6M2,343,33393.8%
PreviousPage 2 of 2